P 95 90 85 80 10Jan 28.00 75 70
Analysts from
OXFORD NANOPORE
P 210 10Jan 14.45 200 190 180 170
Peel Hunt Analysts classify Oxford Nanopore as a 'sell' as the group announced expectations of 32 per cent growth for H2 2023, significantly below the last guidance update of 40 paper cent. Analysts also remain unconvinced by the company's planned strategic pivot to the unmet needs in the clinical, diagnostic and applied market.
(c) 2024 City A.M., source